Shahzad Raza

32PUBLICATIONS
119CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Ngā kōhanga reo (Māori curriculum and pedagogy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 16, 2026
Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma.

|Jun 17, 2026
Fully human BCMA CAR-T therapy in multiple myeloma: lessons from long-term follow-up.

|Jun 03, 2026
Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention.

|May 27, 2026
Smoldering Multiple Myeloma: Early Intervention or Structured Surveillance? A Comprehensive Review of Evidence for and Against Early Therapy.

|Apr 29, 2026
Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

Pageof 6

Frequent Collaborators

20 joint publications

Faiz Anwer

13 joint publications

Jack Khouri

12 joint publications

Danai Dima

8 joint publications

James A Davis